2011
DOI: 10.1016/s1262-3636(11)70928-4
|View full text |Cite
|
Sign up to set email alerts
|

P302 - Traitement de l’hypoglycémie non sévère (HNS) en milieu hospitalier : faut-il un glucide « lent » après le traitement initial ?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
0
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
0
0
Order By: Relevance
“…This is a matter of urgent intervention [48]. Especially since Papadopoulou points out that it would be desirable to overtreat hypoglycemia since glucose infusion in children is safe in case of misdiagnosis [49]. For recurrent/refractory hypoglycemia, the main indicator remains biologically proven liver failure at CH-UPB.…”
Section: Metabolic Managementmentioning
confidence: 99%
“…This is a matter of urgent intervention [48]. Especially since Papadopoulou points out that it would be desirable to overtreat hypoglycemia since glucose infusion in children is safe in case of misdiagnosis [49]. For recurrent/refractory hypoglycemia, the main indicator remains biologically proven liver failure at CH-UPB.…”
Section: Metabolic Managementmentioning
confidence: 99%
“…This is a matter of urgent intervention [48]. Especially since Papadopoulou points out that it would be desirable to overtreat hypoglycemia since glucose infusion in children is safe in case of misdiagnosis [49]. For recurrent/refractory hypoglycemia, the main indicator remains biologically proven liver failure at CH-UPB.…”
Section: Metabolic Managementmentioning
confidence: 99%